Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of C3.ai, Inc. - AI
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
AI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SES AI Corporation - SES
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
SES
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
BSX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of First Solar, Inc. - FSLR
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
FSLR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Distribution Solutions Group, Inc. - DSGR
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
DSGR
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Trip.com Group Limited of Class Action Lawsuit and Upcoming Deadlines – TCOM
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
TCOM
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
March 17, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
AQST
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BlackRock, Inc. - BLK
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
BLK
ORIC® Pharmaceuticals Announces Preclinical Rinzimetostat (ORIC-944) Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
March 17, 2026
From
ORIC Pharmaceuticals
Via
GlobeNewswire
Tickers
ORIC
Galapagos Receives Transparency Notification from Bank of America
March 17, 2026
From
Galapagos NV
Via
GlobeNewswire
Ashland CFO to discuss current market environment at the Gabelli Funds’ 17th Annual Specialty Chemicals Symposium
March 17, 2026
From
Ashland, Inc.
Via
GlobeNewswire
Tickers
ASH
Stardust Power Reports Preliminary 2025 Results and Highlights Development Progress at Muskogee Lithium Refinery
March 17, 2026
From
Stardust Power Inc.
Via
GlobeNewswire
Tickers
SDST
SDSTW
ROHM has Introduced Reference Designs for Three-Phase Inverters Featuring New SiC Power Modules
March 17, 2026
From
ROHM Semiconductor
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Banco Santander, S.A. - SAN
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
SAN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Driven Brands Holdings Inc. of Class Action Lawsuit and Upcoming Deadlines – DRVN
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
DRVN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Apollo Global Management, Inc. of Class Action Lawsuit and Upcoming Deadlines – APO
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
APO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Grocery Outlet Holding Corp. of Class Action Lawsuit and Upcoming Deadlines – GO
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
GO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in monday.com Ltd. of Class Action Lawsuit and Upcoming Deadlines – MNDY
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
MNDY
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hercules Capital, Inc. - HTGC
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
HTGC
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
March 17, 2026
From
OraSure Technologies, Inc.
Via
GlobeNewswire
Tickers
OSUR
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
March 17, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
Tickers
BOLD
What Should Multi-Unit Restaurant Operators Look for When Switching POS Systems? Lavu Publishes 2026 Buyer’s Guide
March 17, 2026
From
Lavu
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Franklin BSP Realty Trust, Inc. of Class Action Lawsuit and Upcoming Deadlines – FBRT
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
FBRT
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Navan, Inc. of Class Action Lawsuit and Upcoming Deadlines – NAVN
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
NAVN
Caring for the Body, PLLC Launches Physician-Led Re-Think Aging Platform to Advance a New Era of Cognitive Decline Prevention and Longevity Care
March 17, 2026
From
Caring for the Body, PLLC
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Tickers
CORT
Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting
March 17, 2026
From
Xilio Therapeutics, Inc.
Via
GlobeNewswire
Tickers
XLO
Greystone Housing Impact Investors LP Schedules Fourth Quarter 2025 Earnings Conference Call and Issues Investor Schedule K-1s
March 17, 2026
From
Greystone Housing Impact Investors LP
Via
GlobeNewswire
Tickers
GHI
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026
March 17, 2026
From
Perspective Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.